- 1、本文档共24页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
guidelines-chest-pain-FT
European Heart Journal (2002) 23, 1153–1176
doi:10.1053/euhj.2002.3194, available online at on
Task Force ReportTask force on the management of chest pain
Members: L. Erhardt (Chairman), J. Herlitz (Secretary), L. Bossaert, M. Halinen,
M. Keltai, R. Koster, C. Marcassa, T. Quinn and H. van WeertContents
Preamble
Scope of the document
Epidemiology
Symptoms and clinical findings
Diagnostic tests in acute chest pain
The electrocardiogram
Biochemical markers
Imaging techniques
Clinical decision making
The five doors and the fast track
The first: the patient
The second: the general practitioner
The third: the dispatch centre
The fourth: the ambulance
The fifth: the hospital
Quality assessmentManuscript submitted 28 January 2002, and accepted 11 February
2002.
Correspondence: Leif Erhardt, MD, PhD, FESC (chairman),
Department of Cardiology, Malmo? University Hospital, SE-205 02
Malmo?, Sweden.Preamble
The Task Force on the management of chest pain was
created by the committee for Scientific and Clinical
Initiatives on 28 June 1997 after formal approval by the
Board of the European Society of Cardiology.
The document was circulated to the members of the
Committee for Scientific and Clinical Initiatives, to the
members of the Board and to the following reviewers:
J. Adgey, C. Blomstro?m-Lundqvist, R. Erbel, W. Klein,
J. L. Lopez-Sendon, L. Ryde?n, M. L. Simoons, C.
Stefanadis, M. Tendera, K. Thygesen. After further
revision it was submitted for approval to the Committee
for Practise Guidelines and Policy Conferences.
The Task Force Report was supported financially
in its entirety by The European Society of Cardiology
and was developed without any involvement of the
pharmaceutical industry.0195-668X/02/$35.00 2002 Published byThe Task Force consists of nine members who were
all active in the preparation of the document. A review
of the literature and position papers was prepared by the
members according to their area of expertize, and
evidence-grading applied wherever pos
您可能关注的文档
- English-English Dictionary.ppt
- enjoy the food - somewhere.doc
- entecavir(恩替卡韦)说明书.pdf
- Enterovirus_71_Infection_of_Human_Dendritic_Cells.pdf
- Environmental risk limits for antifouling substances.pdf
- Epidermal and Dermal Characteristics in Skin Equivalent....pdf
- Epidermal differentiation governs engineered skin biomechanics.pdf
- enhanced Recovery After Surgery (ERAS).pdf
- Epilepsy and Genetic Malformations of the.pdf
- eralreasoningthanstandardlogics,whichdealwithuniversalstatements.Forexample,Nonmonotoniclog.pdf
文档评论(0)